Baidyanath Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.61 M
as on 17-07-2024
- Company Age 27 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 34.99%
(FY 2023)
- Profit 59.52%
(FY 2023)
- Ebitda 27.42%
(FY 2023)
- Net Worth 15.70%
(FY 2023)
- Total Assets 6.51%
(FY 2023)
About Baidyanath Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.61 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Sharma, Rashmi Sharma, and Ameve Sharma serve as directors at the Company.
- CIN/LLPIN
U24233WB1997PTC085256
- Company No.
085256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 1997
- Date of AGM
24 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Baidyanath Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ameve Sharma  | Director | 06-Jul-2011 | Current |
| Ram Sharma | Director | 26-Aug-1997 | Current |
| Rashmi Sharma | Director | 26-Aug-1997 | Current |
Financial Performance and Corporate Structure Insights of Baidyanath Pharma.
Baidyanath Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.99% increase. The company also saw a substantial improvement in profitability, with a 59.52% increase in profit. The company's net worth Soared by an impressive increase of 15.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baidyanath Pharma?
In 2023, Baidyanath Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Goodcare Pharma Pvt LtdActive 31 years 10 monthsRam Sharma, Rashmi Sharma and 1 more are mutual person
Allayurveda.Com Private LimitedActive 24 years 6 monthsRam Sharma, Rashmi Sharma and 1 more are mutual person
- Riaan Wellness Private LimitedActive 32 years 10 months
Ram Sharma, Rashmi Sharma and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Baidyanath Pharma?
Unlock and access historical data on people associated with Baidyanath Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baidyanath Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baidyanath Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
